Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

Record identifier

TN_cdi_proquest_miscellaneous_2315102450

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2315102450

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

Full title

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2019, Vol.20 (12), p.1730-1739

Record Identifier

TN_cdi_proquest_miscellaneous_2315102450

Language

English

Formats

Publication information

Publisher

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_proquest_miscellaneous_2315102450

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2315102450

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card